Cargando…

P373: UPDATES FROM A PHASE II TRIAL OF MINI-HYPER-CVD-INOTUZUMAB WITH OR WITHOUT BLINATUMOMAB IN OLDER PATIENTS WITH NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME (PH)-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA

Detalles Bibliográficos
Autores principales: Haddad, Fadi, Jabbour, Elias, Nasnas, Cedric, Short, Nicholas, Nasr, Lewis, Macaron, Walid, Zoghbi, Marianne, Ravandi, Farhad, Jain, Nitin, Kadia, Tapan, Daver, Naval, Borthakur, Gautam, Dinardo, Courtney, Jacob, Jovitta, Roy, Edith, Loiselle, Christopher, Milton, Anna, Rivera, Juan, Garris, Rebecca, Kantarjian, Hagop
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428515/
http://dx.doi.org/10.1097/01.HS9.0000968404.35630.66
_version_ 1785090488677695488
author Haddad, Fadi
Jabbour, Elias
Nasnas, Cedric
Short, Nicholas
Nasr, Lewis
Macaron, Walid
Zoghbi, Marianne
Ravandi, Farhad
Jain, Nitin
Kadia, Tapan
Daver, Naval
Borthakur, Gautam
Dinardo, Courtney
Jacob, Jovitta
Roy, Edith
Loiselle, Christopher
Milton, Anna
Rivera, Juan
Garris, Rebecca
Kantarjian, Hagop
author_facet Haddad, Fadi
Jabbour, Elias
Nasnas, Cedric
Short, Nicholas
Nasr, Lewis
Macaron, Walid
Zoghbi, Marianne
Ravandi, Farhad
Jain, Nitin
Kadia, Tapan
Daver, Naval
Borthakur, Gautam
Dinardo, Courtney
Jacob, Jovitta
Roy, Edith
Loiselle, Christopher
Milton, Anna
Rivera, Juan
Garris, Rebecca
Kantarjian, Hagop
author_sort Haddad, Fadi
collection PubMed
description
format Online
Article
Text
id pubmed-10428515
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104285152023-08-17 P373: UPDATES FROM A PHASE II TRIAL OF MINI-HYPER-CVD-INOTUZUMAB WITH OR WITHOUT BLINATUMOMAB IN OLDER PATIENTS WITH NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME (PH)-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA Haddad, Fadi Jabbour, Elias Nasnas, Cedric Short, Nicholas Nasr, Lewis Macaron, Walid Zoghbi, Marianne Ravandi, Farhad Jain, Nitin Kadia, Tapan Daver, Naval Borthakur, Gautam Dinardo, Courtney Jacob, Jovitta Roy, Edith Loiselle, Christopher Milton, Anna Rivera, Juan Garris, Rebecca Kantarjian, Hagop Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428515/ http://dx.doi.org/10.1097/01.HS9.0000968404.35630.66 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Haddad, Fadi
Jabbour, Elias
Nasnas, Cedric
Short, Nicholas
Nasr, Lewis
Macaron, Walid
Zoghbi, Marianne
Ravandi, Farhad
Jain, Nitin
Kadia, Tapan
Daver, Naval
Borthakur, Gautam
Dinardo, Courtney
Jacob, Jovitta
Roy, Edith
Loiselle, Christopher
Milton, Anna
Rivera, Juan
Garris, Rebecca
Kantarjian, Hagop
P373: UPDATES FROM A PHASE II TRIAL OF MINI-HYPER-CVD-INOTUZUMAB WITH OR WITHOUT BLINATUMOMAB IN OLDER PATIENTS WITH NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME (PH)-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA
title P373: UPDATES FROM A PHASE II TRIAL OF MINI-HYPER-CVD-INOTUZUMAB WITH OR WITHOUT BLINATUMOMAB IN OLDER PATIENTS WITH NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME (PH)-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA
title_full P373: UPDATES FROM A PHASE II TRIAL OF MINI-HYPER-CVD-INOTUZUMAB WITH OR WITHOUT BLINATUMOMAB IN OLDER PATIENTS WITH NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME (PH)-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA
title_fullStr P373: UPDATES FROM A PHASE II TRIAL OF MINI-HYPER-CVD-INOTUZUMAB WITH OR WITHOUT BLINATUMOMAB IN OLDER PATIENTS WITH NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME (PH)-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA
title_full_unstemmed P373: UPDATES FROM A PHASE II TRIAL OF MINI-HYPER-CVD-INOTUZUMAB WITH OR WITHOUT BLINATUMOMAB IN OLDER PATIENTS WITH NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME (PH)-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA
title_short P373: UPDATES FROM A PHASE II TRIAL OF MINI-HYPER-CVD-INOTUZUMAB WITH OR WITHOUT BLINATUMOMAB IN OLDER PATIENTS WITH NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME (PH)-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA
title_sort p373: updates from a phase ii trial of mini-hyper-cvd-inotuzumab with or without blinatumomab in older patients with newly diagnosed philadelphia chromosome (ph)-negative acute lymphoblastic leukemia
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428515/
http://dx.doi.org/10.1097/01.HS9.0000968404.35630.66
work_keys_str_mv AT haddadfadi p373updatesfromaphaseiitrialofminihypercvdinotuzumabwithorwithoutblinatumomabinolderpatientswithnewlydiagnosedphiladelphiachromosomephnegativeacutelymphoblasticleukemia
AT jabbourelias p373updatesfromaphaseiitrialofminihypercvdinotuzumabwithorwithoutblinatumomabinolderpatientswithnewlydiagnosedphiladelphiachromosomephnegativeacutelymphoblasticleukemia
AT nasnascedric p373updatesfromaphaseiitrialofminihypercvdinotuzumabwithorwithoutblinatumomabinolderpatientswithnewlydiagnosedphiladelphiachromosomephnegativeacutelymphoblasticleukemia
AT shortnicholas p373updatesfromaphaseiitrialofminihypercvdinotuzumabwithorwithoutblinatumomabinolderpatientswithnewlydiagnosedphiladelphiachromosomephnegativeacutelymphoblasticleukemia
AT nasrlewis p373updatesfromaphaseiitrialofminihypercvdinotuzumabwithorwithoutblinatumomabinolderpatientswithnewlydiagnosedphiladelphiachromosomephnegativeacutelymphoblasticleukemia
AT macaronwalid p373updatesfromaphaseiitrialofminihypercvdinotuzumabwithorwithoutblinatumomabinolderpatientswithnewlydiagnosedphiladelphiachromosomephnegativeacutelymphoblasticleukemia
AT zoghbimarianne p373updatesfromaphaseiitrialofminihypercvdinotuzumabwithorwithoutblinatumomabinolderpatientswithnewlydiagnosedphiladelphiachromosomephnegativeacutelymphoblasticleukemia
AT ravandifarhad p373updatesfromaphaseiitrialofminihypercvdinotuzumabwithorwithoutblinatumomabinolderpatientswithnewlydiagnosedphiladelphiachromosomephnegativeacutelymphoblasticleukemia
AT jainnitin p373updatesfromaphaseiitrialofminihypercvdinotuzumabwithorwithoutblinatumomabinolderpatientswithnewlydiagnosedphiladelphiachromosomephnegativeacutelymphoblasticleukemia
AT kadiatapan p373updatesfromaphaseiitrialofminihypercvdinotuzumabwithorwithoutblinatumomabinolderpatientswithnewlydiagnosedphiladelphiachromosomephnegativeacutelymphoblasticleukemia
AT davernaval p373updatesfromaphaseiitrialofminihypercvdinotuzumabwithorwithoutblinatumomabinolderpatientswithnewlydiagnosedphiladelphiachromosomephnegativeacutelymphoblasticleukemia
AT borthakurgautam p373updatesfromaphaseiitrialofminihypercvdinotuzumabwithorwithoutblinatumomabinolderpatientswithnewlydiagnosedphiladelphiachromosomephnegativeacutelymphoblasticleukemia
AT dinardocourtney p373updatesfromaphaseiitrialofminihypercvdinotuzumabwithorwithoutblinatumomabinolderpatientswithnewlydiagnosedphiladelphiachromosomephnegativeacutelymphoblasticleukemia
AT jacobjovitta p373updatesfromaphaseiitrialofminihypercvdinotuzumabwithorwithoutblinatumomabinolderpatientswithnewlydiagnosedphiladelphiachromosomephnegativeacutelymphoblasticleukemia
AT royedith p373updatesfromaphaseiitrialofminihypercvdinotuzumabwithorwithoutblinatumomabinolderpatientswithnewlydiagnosedphiladelphiachromosomephnegativeacutelymphoblasticleukemia
AT loisellechristopher p373updatesfromaphaseiitrialofminihypercvdinotuzumabwithorwithoutblinatumomabinolderpatientswithnewlydiagnosedphiladelphiachromosomephnegativeacutelymphoblasticleukemia
AT miltonanna p373updatesfromaphaseiitrialofminihypercvdinotuzumabwithorwithoutblinatumomabinolderpatientswithnewlydiagnosedphiladelphiachromosomephnegativeacutelymphoblasticleukemia
AT riverajuan p373updatesfromaphaseiitrialofminihypercvdinotuzumabwithorwithoutblinatumomabinolderpatientswithnewlydiagnosedphiladelphiachromosomephnegativeacutelymphoblasticleukemia
AT garrisrebecca p373updatesfromaphaseiitrialofminihypercvdinotuzumabwithorwithoutblinatumomabinolderpatientswithnewlydiagnosedphiladelphiachromosomephnegativeacutelymphoblasticleukemia
AT kantarjianhagop p373updatesfromaphaseiitrialofminihypercvdinotuzumabwithorwithoutblinatumomabinolderpatientswithnewlydiagnosedphiladelphiachromosomephnegativeacutelymphoblasticleukemia